Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - rivastigmine hydrogen tartrate, quantity: 2.4 mg - capsule - excipient ingredients: titanium dioxide; stearic acid; iron oxide yellow; maize starch; gelatin; microcrystalline cellulose; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - rivastigmine is indicated for the treatment of patients with mild to moderately severe dementia of the alzheimer's type

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - rivastigmine hydrogen tartrate, quantity: 7.2 mg - capsule - excipient ingredients: iron oxide yellow; stearic acid; microcrystalline cellulose; titanium dioxide; maize starch; iron oxide red; gelatin; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - rivastigmine is indicated for the treatment of patients with mild to moderately severe dementia of the alzheimer's type

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - rivastigmine hydrogen tartrate, quantity: 7.2 mg - capsule - excipient ingredients: gelatin; iron oxide yellow; iron oxide red; microcrystalline cellulose; maize starch; titanium dioxide; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - rivastigmine is indicated for the treatment of patients with mild to moderately severe dementia of the alzheimer's type

Καναδάς - Αγγλικά - Health Canada

dr reddy's laboratories ltd - rivastigmine (rivastigmine hydrogen tartrate) - capsule - 1.5mg - rivastigmine (rivastigmine hydrogen tartrate) 1.5mg - parasympathomemetic (cholinergic) agents

Καναδάς - Αγγλικά - Health Canada

dr reddy's laboratories ltd - rivastigmine (rivastigmine hydrogen tartrate) - capsule - 3.0mg - rivastigmine (rivastigmine hydrogen tartrate) 3.0mg - parasympathomemetic (cholinergic) agents

Καναδάς - Αγγλικά - Health Canada

dr reddy's laboratories ltd - rivastigmine (rivastigmine hydrogen tartrate) - capsule - 4.5mg - rivastigmine (rivastigmine hydrogen tartrate) 4.5mg - parasympathomemetic (cholinergic) agents

Καναδάς - Αγγλικά - Health Canada

dr reddy's laboratories ltd - rivastigmine (rivastigmine hydrogen tartrate) - capsule - 6.0mg - rivastigmine (rivastigmine hydrogen tartrate) 6.0mg - parasympathomemetic (cholinergic) agents

Ισραήλ - Αγγλικά - Ministry of Health

dexcel ltd, israel - rivastigmine as hydrogen tartrate - hard capsule - rivastigmine as hydrogen tartrate 1.5 mg - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementiaassociated with parkinson's disease.

Ισραήλ - Αγγλικά - Ministry of Health

dexcel ltd, israel - rivastigmine as hydrogen tartrate - hard capsule - rivastigmine as hydrogen tartrate 3 mg - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementiaassociated with parkinson's disease.

Ισραήλ - Αγγλικά - Ministry of Health

dexcel ltd, israel - rivastigmine as hydrogen tartrate - hard capsule - rivastigmine as hydrogen tartrate 4.5 mg - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementiaassociated with parkinson's disease.